Methylthioninium chloride
Provayblue (methylene blue) is a small molecule pharmaceutical. Methylene blue was first approved as Provayblue on 2016-04-08. It is used to treat cyanosis, herpes simplex, lithiasis, methemoglobinemia, and poisoning amongst others in the USA.
| Trade Name | Provayblue |
|---|---|
| Common Name | Methylthioninium chloride |
| Indication | cyanosis, herpes simplex, lithiasis, methemoglobinemia, poisoning, urinary tract infections |
| Drug Class |
